Ketoprofen/omeprazole regulatory update

Meda AB (SSE:MEDA, Solna, Sweden) said the U.K. approved the company's ketoprofen/omeprazole combination product to treat pain and inflammation. The combination of an NSAID and a proton pump inhibito...